≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other or unspecified common variable immunodeficiency

DOID EFO Endpoint Browser PheWeb

D3_CVIDNAS

obsolete_common variable immunodeficiency: ['A hypogammaglobulinemia that is results in insufficient production of antibodies needed to respond to exposure of pathogens and is characterized by low Ig levels with phenotypically normal B cells that can proliferate but do not develop into Ig-producing cells. Patients with common variable immunodeficiency have marked reduction in serum levels of both immunoglobulin G (IgG) and immunoglobulin A (IgA); about half of these patients also have reduced immunoglobulin M (IgM).', 'A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.', 'Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.']

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

119

4. Check minimum number of events

None

119

5. Include endpoints

None

119

6. Filter based on genotype QC (FinnGen only)

119

Control definitions (FinnGen only)

Control exclude
D3_IMMUNEMECHANISM

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 443 255 186
Only index persons 415 243 172
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 46.95 48.76 44.63
Only index persons 45.68 47.31 43.38

-FinnGen-

Key figures

All Female Male
Number of individuals 119 77 42
Unadjusted period prevalence (%) 0.02 0.03 0.02
Median age at first event (years) 47.58 48.76 45.42

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
104
Matched controls
1039
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
113.2
87
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
67.1
57
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
64.4
55
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
55.2
48
*
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
35.5
32
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
27.3
25
*
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
26.1
24
*
6BA02
NOMESCO Finland
NA
+∞
25.0
23
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
20.4
21.2
32
22
ZX120
NOMESCO Finland
Intravenous
11.4
20.6
42
58
J47
ICD-10 Finland
Bronchiectasis
86.6
19.5
21
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
19.4
18
*
H02AB06
ATC
prednisolone; systemic
7.2
18.5
80
330
TDM10
NOMESCO Finland
Puncture of maxillary antrum
21.0
18.3
27
17
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
18.3
17
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
7.7
17.8
49
108
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
10.9
16.9
34
44
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
14.0
15.1
26
24
J01MA12
ATC
levofloxacin; systemic
6.7
14.9
44
103
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.1
14.3
39
81
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.5
14.2
53
164
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.2
14.1
69
284
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
11.0
13.9
27
32
J01MA14
ATC
moxifloxacin; systemic
8.6
13.5
31
49
TPH04
NOMESCO Finland
Cathetrisation of vein
5.7
13.2
45
123
UDH02
NOMESCO Finland
Rhinopharyngoscopy
9.9
12.3
25
32
Z01.8
ICD-10 Finland
Other specified special examinations
5.2
12.3
46
138
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
22.2
12.1
17
9
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
11.0
12.0
23
26
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
12.8
11.9
21
20
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
11.7
11
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
8.8
11.1
24
34
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.3
11.1
25
38
J01FA06
ATC
roxithromycin; oral
4.2
10.8
66
306
J45.8
ICD-10 Finland
Mixed asthma
21.6
10.6
15
8
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
+∞
10.6
10
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.2
10.5
51
192
J45.1
ICD-10 Finland
Nonallergic asthma
8.4
10.3
23
34
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
8.4
10.3
23
34
R50.9
ICD-10 Finland
Fever, unspecified
5.6
10.2
32
76
SPAT1262
SPAT
Handing over of treatment supplies
5.2
10.0
34
89
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
9.6
9.9
20
25
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
3.9
9.8
72
379
J01FA15
ATC
telithromycin; oral
6.4
9.6
26
51
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.8
9.6
19
23
J01FF01
ATC
clindamycin; systemic
3.9
9.4
48
186
WW200
NOMESCO Finland
Immunization
17.7
9.3
14
9
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.5
9.1
36
109
J01.0
ICD-10 Finland
Acute maxillary sinusitis
4.1
9.1
41
141
C01CA24
ATC
epinephrine; parenteral
7.2
9.1
22
37
J45.9
ICD-10 Finland
Asthma, unspecified
4.6
9.0
35
104
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.8
8.6
25
54
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
8.4
8
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
+∞
8.4
8
*
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
8.4
8
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
8.4
8
*
UJF32
NOMESCO Finland
Coloscopy
4.1
8.3
37
124
J32.4
ICD-10 Finland
Chronic pansinusitis
36.5
8.2
10
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.2
8.2
35
113
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
14.6
8.1
13
10
TGC00
NOMESCO Finland
Bronchial lavation
14.6
8.1
13
10
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.7
7.8
28
76
J01MA02
ATC
ciprofloxacin; systemic
3.4
7.8
51
231
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
14.9
7.6
12
9
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
7.4
7
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
6.0
7.1
19
37
P01AB01
ATC
metronidazole; oral, rectal
3.1
7.0
55
277
C03CA01
ATC
furosemide; systemic
3.7
6.9
33
116
R03DA04
ATC
theophylline; systemic, rectal
8.8
6.9
14
18
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.1
6.9
72
438
R03AC12
ATC
salmeterol; inhalant
9.7
6.8
13
15
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.8
6.6
22
55
J05AB11
ATC
valaciclovir; oral
4.2
6.6
26
77
D70.89
ICD-10 Finland
Neutropenic splenomegaly
74.2
6.5
7
*
ZXA10
NOMESCO Finland
Bilateral
3.8
6.4
29
97
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
19.5
6.4
9
5
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
28.6
6.3
8
*
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
+∞
6.3
6
*
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
6.3
6
*
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
+∞
6.3
6
*
J01DB01
ATC
cefalexin; oral
4.5
6.3
95
727
J02AC01
ATC
fluconazole; systemic
2.9
6.2
56
300
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.0
6.2
42
190
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.6
6.2
21
54
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.6
6.1
29
101
D07BA04
ATC
hydrocortisone and antiseptics; topical
4.4
6.1
22
60

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
48
6
131.93
47.15
2.2
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
84
214
10.95
37.54
4.9
1.4
g/l
1.2
2.2
5.68
55
134
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
25
11
28.51
35.01
2.0
1.4
e6/l
917.0
717.2
—
5
6
(3005322) IgE [Units/volume] in Serum or Plasma
45
59
11.66
34.90
2.3
1.2
u/ml
59.4
508.1
0.58
26
54
(42870588) Differential panel, method unspecified - Blood
90
310
8.81
27.85
18.4
5.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
23
14.89
27.48
1.9
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
29
5
75.73
26.39
1.9
1.4
e6/l
135.0
—
—
20
0
(4062490)
30
9
43.87
24.78
2.1
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
37
57
8.97
24.65
2.6
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
19
10
22.42
24.43
5.4
3.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
23
18
15.60
24.43
3.4
2.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
21
13.34
22.25
1.4
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
19
13.98
21.99
1.5
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
64
195
5.94
21.28
6.7
4.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
36
63
7.76
21.25
11.0
3.8
%
0.6
0.2
1.35
13
17
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
48
127
5.66
18.35
2.9
1.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
34
65
6.92
18.29
12.8
4.1
%
0.0
0.0
0.48
13
22
(3042936) Bacteria identified in Isolate by Culture
46
118
5.72
18.19
3.2
2.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
45
114
5.74
18.03
6.5
7.2
mmol/l
1.0
1.1
0.36
45
108
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
61
206
5.02
17.26
2.9
2.0
mg/l
3.1
3.2
0.04
56
182
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
10
17.02
17.06
2.4
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
10
17.02
17.06
2.4
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
42
105
5.64
16.98
2.9
2.6
%
18.4
24.1
1.74
36
89
(3010503) CD19 cells [#/volume] in Blood
21
7
35.95
16.77
2.3
1.0
e9/l
0.1
0.2
—
21
7
(3017181) Myelocytes/100 leukocytes in Blood
34
71
6.30
16.64
12.8
3.9
%
0.6
0.8
0.20
13
24
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
15
0
+∞
15.99
1.8
0.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
26
44
7.28
15.54
2.7
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
29
56
6.53
15.28
4.4
2.8
e9/l
71.9
80.7
0.51
24
40
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
15
12.17
14.97
1.5
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
13
13.06
14.71
1.4
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
42
118
4.96
14.60
1.9
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
27
51
6.55
14.50
2.1
2.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
30
63
6.03
14.47
13.8
4.1
%
0.0
0.1
0.48
12
18
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
94
488
5.41
14.39
10.6
6.1
umol/l
10.5
10.4
0.03
94
461
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
111
726
8.86
13.90
21.9
7.1
u/l
94.8
76.8
3.01
111
675
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
85
417
4.63
13.81
12.1
8.0
mmol/l
1.2
1.2
0.36
79
359
(3034770) Mitochondria Ab [Titer] in Serum
20
29
8.09
13.60
1.6
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
70
311
4.04
12.80
7.8
6.4
inr
1.1
1.1
0.98
23
97
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
35
94
4.86
12.69
2.1
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
12
12.04
12.17
1.4
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
35
100
4.54
11.67
2.8
2.3
nmol/l
331.9
374.1
0.60
35
94
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
11
0
+∞
11.64
2.4
0.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
11
12.02
11.24
1.3
1.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
19
33
6.66
10.92
4.8
3.5
g/l
0.1
0.6
0.60
12
14
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
15
9.61
10.43
1.4
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
10
12.02
10.31
2.8
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
10
12.02
10.31
1.3
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
95
4.24
10.04
2.3
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
64
303
3.41
9.95
4.7
3.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
16
9.00
9.93
9.6
2.9
%
52.9
51.6
0.14
13
16
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
16
9.00
9.93
1.4
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
16
9.00
9.93
9.2
2.6
e9/l
3.3
3.9
0.43
13
16
(3000492) Spirometry study
31
92
4.20
9.71
3.5
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
57
256
3.35
9.59
4.1
3.5
ph
7.4
7.4
0.21
14
44
(40760888) Immunoglobulin light chains.free panel - Serum
11
12
10.00
9.12
1.4
4.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
35
121
3.68
8.78
1.5
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
19
7.56
8.63
1.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
34
118
3.63
8.46
3.3
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
64
328
3.06
8.31
2.4
1.9
pmol/l
92.1
98.6
0.36
39
164
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
11
9.83
8.20
1.5
2.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
53
247
3.07
8.10
17.2
7.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
28
5.99
7.95
3.7
2.5
—
—
—
0
0
(44790047)
12
8
16.49
7.90
1.3
1.4
—
—
—
0
0
(44790049)
12
8
16.49
7.90
1.3
1.4
—
—
—
0
0
(44806118)
12
8
16.49
7.90
1.3
1.4
—
—
—
0
0
(44790048)
12
8
16.49
7.90
1.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
53
250
3.02
7.89
18.4
4.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
50
231
3.01
7.69
1.4
1.3
u/ml
3.1
2.4
—
10
53
(4035726)
27
85
3.82
7.69
1.7
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
9
14.65
7.57
2.6
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
9
14.65
7.57
1.3
2.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
26
5.97
7.44
2.9
2.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
50
238
2.90
7.21
3.9
3.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
27
5.74
7.16
3.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
17
7.03
6.90
3.9
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
6
18.01
6.87
2.9
5.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
20
55
4.17
6.81
2.4
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
78
479
2.82
6.76
5.0
3.2
estimate
0.0
0.0
0.00
23
96
(3021601) Nitrite [Presence] in Urine by Test strip
77
472
2.79
6.66
6.4
4.6
estimate
0.0
0.0
0.00
22
96
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
14
29
5.34
6.64
4.4
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
53
270
2.74
6.61
3.9
3.0
e6/l
16.9
294.1
0.59
45
203
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
18
6.63
6.55
3.9
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
18
6.63
6.55
3.9
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
18
6.63
6.55
4.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
18
6.63
6.55
3.9
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
18
6.63
6.55
4.0
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
49
241
2.76
6.53
3.9
3.0
e6/l
0.6
0.4
0.26
41
177
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
7
15.43
6.52
1.4
2.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
77
478
2.73
6.39
4.8
3.4
estimate
0.0
0.0
0.00
23
90
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
18
48
4.24
6.36
6.2
3.2
mmol/l
1.8
0.9
0.48
12
33
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
16
39
4.58
6.31
1.5
2.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
39
4.58
6.31
2.1
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
95
662
3.16
6.24
8.5
3.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
23
5.69
6.15
2.1
2.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
35
149
2.91
6.05
2.2
1.4
titre
128.0
544.5
—
5
31
(3018095) Leukocytes [#/volume] in Urine
58
323
2.55
5.88
4.9
3.5
e6/l
56.8
52.2
0.04
46
217
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
7
13.76
5.68
1.4
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
7
13.76
5.68
1.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
7
13.76
5.68
1.4
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
38
4.37
5.63
1.6
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
25
5.23
5.63
1.3
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
29
117
2.96
5.48
1.6
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
9
10.69
5.12
1.3
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
9
10.69
5.12
3.7
4.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
46
248
2.39
4.82
5.2
3.4
estimate
0.0
0.0
0.00
22
90
(3011397) Hemoglobin [Presence] in Urine by Test strip
41
210
2.45
4.80
4.0
3.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
41
211
2.44
4.75
1.8
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
53
307
2.31
4.68
4.8
3.0
ng/l
20.6
39.9
0.62
37
174
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
11
8.74
4.65
1.3
1.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
5
14.74
4.63
1.1
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
38
191
2.45
4.62
3.6
2.3
ng/l
852.2
798.8
0.05
33
155
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
8
10.61
4.59
2.3
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
18
61
3.30
4.51
5.8
3.6
mmol/l
1.2
1.2
0.69
18
55
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
69
452
2.25
4.48
4.6
4.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
17
56
3.38
4.45
3.0
3.5
e9/l
5.6
4.0
1.13
11
49
(3037756) Immunofixation for Serum or Plasma
9
12
8.01
4.44
1.2
2.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
14
42
3.64
4.19
2.7
3.4
mmol/l
25.2
24.9
0.10
14
42
(3000991) Gas panel - Venous blood
19
70
3.04
4.15
8.3
8.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
59
371
2.17
4.15
5.2
3.2
—
—
—
0
0
(4010399)
18
65
3.08
4.07
1.9
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
12
33
3.93
4.03
1.3
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
50
298
2.17
3.99
3.2
2.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
15
6.39
3.89
2.6
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
22
92
2.71
3.83
8.6
12.8
mmol/l
0.1
1.7
0.98
15
70
(36660697) Celiac disease serology panel - Serum
22
92
2.71
3.83
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
16
56
3.15
3.80
3.3
13.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
12
7.05
3.74
1.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
35
3.70
3.73
1.3
3.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
43
249
2.14
3.64
3.3
2.5
umol/l
7249.5
6054.4
0.06
43
219
(46235355) HIV 1 and 2 tests - Meaningful Use set
43
249
2.14
3.64
2.1
2.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
41
3.44
3.61
7.7
3.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
45
266
2.11
3.61
3.6
2.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
17
5.63
3.58
1.1
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
31
3.81
3.57
1.9
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
31
3.81
3.57
1.9
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
13
6.51
3.56
1.0
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
37
3.49
3.44
3.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
32
3.69
3.42
1.9
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
14
6.04
3.40
1.1
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
7
8.94
3.30
1.0
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
7
8.94
3.30
2.3
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
40
233
2.08
3.29
4.4
4.0
mg/mmol
6.7
15.5
0.83
30
147
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
108
910
3.02
3.26
32.0
10.8
ml/min/173m2
89.3
88.1
0.21
97
748
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
8
7.82
3.09
1.5
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
8
7.82
3.09
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
8
7.82
3.09
1.5
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
5
10.35
3.00
1.8
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
5
10.35
3.00
1.4
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
5
10.35
3.00
1.8
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
5
10.35
3.00
1.8
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
5
10.35
3.00
1.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
5
10.35
3.00
2.6
1.2
ug/l
44.2
79.8
—
5
5
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
5
10.35
3.00
1.8
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
95
766
2.19
3.00
4.3
4.0
pmol/l
14.7
14.7
0.01
90
713
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
38
224
2.02
3.00
3.4
2.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
38
225
2.01
2.95
3.7
3.3
mg/l
36.8
84.4
0.73
28
148
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
12
41
3.14
2.95
4.3
3.0
%
46.3
53.3
0.31
12
41
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
9
6.95
2.90
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
6
8.63
2.77
1.8
1.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
6
8.63
2.77
1.0
1.2
mg/l
3.2
3.0
—
5
6
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
6
8.63
2.77
3.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
6
8.63
2.77
1.2
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
6
8.63
2.77
1.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
14
5.24
2.77
2.4
2.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
10
6.25
2.73
2.0
2.5
%
90.6
89.1
—
6
10
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
38
3.09
2.66
11.3
22.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
15
4.89
2.64
1.6
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
17
76
2.44
2.58
3.6
3.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
11
5.68
2.57
1.3
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
6
11
5.68
2.57
5.2
1.3
umol/l
8.9
12.1
—
6
11
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
11
5.68
2.57
1.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
7
7.39
2.57
7.2
3.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
27
149
2.05
2.51
1.7
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
21
4.01
2.51
1.3
2.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
102
866
2.24
2.51
43.0
14.9
%
14.0
13.5
2.12
102
857
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
58
2.60
2.47
1.7
1.2
—
—
—
0
0
(3019225) pH of Specimen
16
71
2.45
2.47
14.2
4.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
12
5.20
2.43
1.3
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
12
5.20
2.43
1.2
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
17
4.30
2.40
1.1
2.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
42
274
1.82
2.39
4.8
2.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
13
4.80
2.30
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
38
243
1.83
2.29
1.6
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
18
4.06
2.29
1.3
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
16
74
2.34
2.27
5.0
3.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
42
2.78
2.25
1.4
1.5
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
7
19
3.85
2.18
3.1
2.6
kpa
5.1
5.1
—
7
19
(3027315) Oxygen [Partial pressure] in Blood
7
19
3.85
2.18
3.0
2.6
kpa
8.5
9.1
—
7
19
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
25
3.35
2.13
1.3
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
56
2.48
2.13
1.4
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
15
4.15
2.06
1.3
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
21
3.47
2.00
1.1
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
39
2.71
1.97
1.9
3.4
%
1.7
1.2
—
10
39
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
27
3.10
1.97
2.0
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
11
4.69
1.96
1.8
2.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
17
3.66
1.86
1.5
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
67
2.23
1.84
2.7
2.6
ml/min/173m2
82.9
70.9
—
7
29
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
12
4.30
1.84
1.2
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
5
12
4.30
1.84
1.2
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
5
12
4.30
1.84
2.2
2.5
mmol/l
1.9
1.6
—
5
12
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
29
2.88
1.83
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
18
3.45
1.77
2.8
1.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
24
3.03
1.75
1.4
1.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
24
3.03
1.75
1.3
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
105
935
2.05
1.75
33.3
13.4
%
40.4
40.6
0.16
74
741
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
89
755
1.71
1.74
4.1
3.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
185
1.75
1.73
1.3
1.3
iu/ml
23.8
46.4
—
5
62
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
13
62
2.23
1.73
6.2
1.9
ng/l
71.2
120.0
0.86
13
54
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
139
1.81
1.63
2.5
2.8
e6/l
1.5
2.6
0.60
11
71
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
14
3.68
1.63
2.2
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
51
384
1.57
1.60
2.1
1.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
34
232
1.65
1.59
1.7
1.9
mg/l
0.7
0.6
0.18
26
174
(40761536) Microorganisms panel - Urine sediment
15
79
2.03
1.58
6.0
3.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
27
174
1.71
1.55
5.4
3.2
ng/l
17.8
130.4
1.04
17
111
(3044889) 12 lead EKG panel
78
650
1.58
1.55
4.6
3.2
—
—
—
0
0
(3002256) Pathology report gross observation
19
117
1.74
1.27
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
28
192
1.60
1.27
1.4
1.3
u/ml
1.1
6.5
1.69
12
79
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
94
1.81
1.25
1.4
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
39
2.13
1.18
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
137
1.65
1.15
1.8
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
21
2.44
1.10
1.2
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
21
2.44
1.10
1.2
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
149
1.58
1.05
2.2
2.7
e6/l
2.0
0.8
—
10
81
(3020891) Body temperature
7
35
2.06
1.02
2.3
5.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
36
2.00
0.99
2.0
1.3
—
—
—
0
0
(3013512) EKG study
32
240
1.46
0.96
4.6
3.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
112
1061
1.94
0.95
33.1
10.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
42
1.97
0.90
2.3
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
13
80
1.70
0.89
1.9
1.3
iu/ml
11.3
130.2
—
6
33
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
33
1.86
0.80
1.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
25
0.00
0.80
0.0
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
25
0.00
0.80
0.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
39
1.84
0.74
1.6
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
25
2.04
0.73
1.6
2.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
26
1.96
0.71
1.8
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
128
0.60
0.68
1.1
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
28
1.82
0.67
1.4
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
20
0.00
0.61
0.0
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
37
1.65
0.56
1.7
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
38
1.61
0.55
1.2
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
33
393
0.78
0.55
2.0
2.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
14
102
1.42
0.50
1.6
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
94
1.43
0.48
2.8
2.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
80
1.41
0.40
2.5
1.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
79
0.62
0.37
1.6
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
42
1.45
0.36
3.3
2.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
33
294
1.17
0.27
1.5
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
39
1.29
0.23
1.0
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
39
1.29
0.23
1.4
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.8
—
17.4
—
0
11
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(1002224) Polysomnography panel
6
48
1.26
0.20
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
17
147
1.18
0.19
2.1
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
59
1.20
0.18
1.4
2.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
110
1.20
0.18
8.5
6.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
68
1.19
0.17
1.5
2.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
19
210
0.89
0.13
1.4
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
92
901
1.09
0.11
46.0
15.6
g/l
330.7
333.4
1.85
92
896
(3022621) pH of Urine by Test strip
6
57
1.06
0.08
3.8
2.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
71
0.84
0.08
2.7
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
74
1.09
0.07
1.8
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
74
1.09
0.07
1.8
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
74
1.09
0.07
1.6
2.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
74
1.09
0.07
1.6
2.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
178
1.08
0.06
3.1
2.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
169
1.08
0.05
3.2
2.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
18
169
1.08
0.05
3.2
3.9
%
26.3
24.0
—
8
69
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
99
980
1.06
0.04
4.3
4.5
mmol/l
2.7
2.8
0.76
93
924
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
10
103
0.97
0.00
4.9
4.2
%
30.7
31.3
—
10
69
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
10.2
—
0
5
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
1.0
—
0
8
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
51
0.98
0.00
3.2
3.6
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
61
0.98
0.00
1.2
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_CVIDNAS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have D3_CVIDNAS.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: D3_CVIDNAS – Other or unspecified common variable immunodeficiency

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data